Why the study?
Does the addition of Vitamin C to glyceryltrinitrate or the use of pentaerithrityltetranitrate prevent vascular tolerance and platelet upregulation compared to glyceryltrinitrate alone?
Does the addition of Vitamin C to glyceryltrinitrate or the use of pentaerithrityltetranitrate prevent vascular tolerance and platelet upregulation compared to glyceryltrinitrate alone?
Co-administration of Vitamin C with glyceryltrinitrate or the use of pentaerithrityltetranitrate prevents nitrate-induced vascular tolerance and platelet upregulation seen with continuous glyceryltrinitrate therapy.
May support trials of Vitamin C or PETN with GTN to limit tolerance; leaves open clinical translation.
Enhanced formation of oxygen-derived radicals O plays a dominant role in the development of nitrate tolerance. In 18 healthy subjects, this study tested the effect of additional vitamin C (Vit-C) administration (1 g three times daily) on glyceryltrinitrate (GTN)-induced hemodynamic changes during 3 days of nonintermittent transdermal administration of GTN (0.4 mg/h) in comparison with administration of pentaerithrityltetranitrate (PETN, 40 mg three times daily, orally). GTN caused an immediate significant rise in arterial conductivity (a/b ratio of dicrotic pulse pressure, from 2.33 +/- 0.06 to 2.52 +/- 0.06). Within 2 days of GTN administration, the a/b ratio progressively decreased and reached pre-GTN control levels, documenting tolerance. However, the administration of GTN along with Vit-C or with PETN alone induced changes in the a/b ratio and in the orthostatic reaction, which were fully maintained for the period of treatment. This vascular tolerance seen after GTN treatment was paralleled by an upregulation of ex vivo platelet activity, which was evident from a rise in aggregation from 29.2 +/- 2.8% at control day to 85.4 +/- 8.5% at day 3, and additionally from thrombin-induced increases of intracellular Ca concentration from 494 +/- 60 nM at control day to 741 +/- 37 nM at day 3. This upregulation was not observed during PETN or GTN; with additional Vit-C administration. Administration of PETN or GTN, the latter supplemented by Vit-C, induced neither vascular tolerance nor the upregulation of washed platelet activity during nonintermittent administration, in contrast to GTN without Vit-C. This is explained by a diminished formation of reactive oxygen species when PETN or when GTN along with Vit-C is used.
No takes yet. Share an insight, caveat, or question.
Fink et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: